Kyverna Therapeutics Inc. (KYTX)
NASDAQ: KYTX
· Real-Time Price · USD
3.53
-0.01 (-0.28%)
At close: Aug 15, 2025, 3:59 PM
3.58
1.42%
After-hours: Aug 15, 2025, 06:09 PM EDT
-0.28% (1D)
| Bid | 3.28 |
| Market Cap | 152.66M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -145.42M |
| EPS (ttm) | -3.68 |
| PE Ratio (ttm) | -0.96 |
| Forward PE | -1.03 |
| Analyst | Buy |
| Ask | 4.2 |
| Volume | 271,508 |
| Avg. Volume (20D) | 462,319 |
| Open | 3.55 |
| Previous Close | 3.54 |
| Day's Range | 3.50 - 3.76 |
| 52-Week Range | 1.78 - 8.78 |
| Beta | 3.07 |
About KYTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KYTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for KYTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+13.66%
Kyverna Therapeutics shares are trading higher aft...
Unlock content with
Pro Subscription
2 months ago · https://www.defenseworld.net
Squarepoint Ops LLC Acquires New Holdings in Kyverna Therapeutics, Inc. (NASDAQ:KYTX)Squarepoint Ops LLC acquired a new stake in Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm ...